Elis Ferreira Garcia

Ms. Elis Ferreira Garcia

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Revista de Gestão e Secretariado
Verified
Journal Article
Open access
LBLuana Mendonça Marques Ramos Bueno
Luana Mendonça Marques Ramos Bueno
LPLayra Eugenio Pedreira
Layra Eugenio Pedreira
ISIsamara Alves dos Santos
Isamara Alves dos Santos
AOAna Laura Orsi
Ana Laura Orsi
CFCaroline Priscila Furlanetto
Caroline Priscila Furlanetto
WDWalmirton Bezerra D'Alessandro
Walmirton Bezerra D'Alessandro
Considerando a elevada incidência de parasitoses intestinais em crianças e a necessidade de estratégias educativas que promovam o aprendizado de forma lúdica e efetiva, torna-se relevante avaliar métodos inovadores de ensino em saúde. Objetiva-se analisar os efeitos do uso de modelos tridimensionais (3D) na compreensão sobre parasitoses por estudantes do ensino fundamental. Para tanto, procede-se a uma intervenção educativa realizada com 49 alunos de duas escolas municipais de Paraíso do Tocantins – TO, divididos em dois grupos: um recebeu a palestra tradicional e o outro participou da atividade com o auxílio de modelos 3D representando os parasitas estudados. Desse modo, observa-se que o grupo com modelos apresentou melhor desempenho nas questões referentes à transmissão e prevenção das parasitoses, além de maior assimilação conceitual dos agentes causadores. O que permite concluir que o uso de modelos tridimensionais favorece o aprendizado e desperta maior interesse dos estudantes, configurando-se como uma ferramenta eficaz para a educação em saúde no ambiente escolar.

Verified
Journal Article
Open access
PDF file
Maykon Jhuly Martins de PaivaMaykon Jhuly Martins de Paiva
Maykon Jhuly Martins de Paiva
CFCaroline Priscila Furlanetto
Caroline Priscila Furlanetto
EGElis Ferreira Garcia
Elis Ferreira Garcia
LPLayra Eugenio Pedreira
Layra Eugenio Pedreira
WDWalmirton Bezerra D'Alessandro
Walmirton Bezerra D'Alessandro
MTMárcio Trevisan
Márcio Trevisan
Natural products continue to provide pharmacologically relevant scaffolds for anticancer drug discovery, with alkaloids from the Amaryllidaceae family among the most structurally diverse and biologically investigated classes of plant secondary metabolites. Within this family, the Brazilian genus Griffinia—comprising approximately 21 species predominantly endemic to the Atlantic Forest and Cerrado—remains substantially underrepresented in the phytochemical and pharmacological literature, with fewer than five species subjected to any level of biological evaluation and no genus-wide mechanistic profile available to date. This critical review specifically examines what the current literature reports regarding the anticancer relevance of Griffinia alkaloids, addressing a gap that has not been systematically investigated in prior Amaryllidaceae reviews. Six structural classes—lycorine-, galanthamine-, crinine-, hemanthamine-, montanine-, and homolycorine-type alkaloids—have been detected in Griffinia species primarily through gas chromatography–mass spectrometry and liquid chromatography–mass spectrometry profiling; however, isolation and direct biological validation have been reported for only one species, Griffinia gardneriana, in which lycorine and related compounds exhibit cytotoxic and genotoxic activities associated with caspase-3-mediated apoptosis. This finding constitutes the sole genus-specific mechanistic anchor currently available. The broader biological literature on Amaryllidaceae alkaloids—encompassing apoptosis induction, cell cycle arrest, redox imbalance, and modulation of phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), nuclear factor kappa B (NF-κB), and mitogen-activated protein kinase (MAPK) signaling—is explicitly used here as contextual evidence for the structural classes detected in Griffinia, not as proof of genus-level activity. This distinction is central to the evidentiary framework of the review and is maintained throughout. Approximately 70% of evaluated Amaryllidaceae species lack comprehensive phytochemical and biological characterization, a limitation that is directly reflected in Griffinia. Future research priorities include rigorous compound isolation and structural elucidation across underexplored species, genus-specific bioactivity testing in well-defined cancer models, and mechanism-oriented studies anchored in direct experimental evidence rather than structural analogies. Semi-synthetic optimization and multi-omic approaches represent longer-term but tractable avenues once the primary pharmacological characterization is established.